UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 237

Sortiert nach

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

Journal of clinical oncology, 2012-05, Vol.30 (13), p.1534-1540

2012

Volltextzugriff (PDF)

Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2014-04, Vol.32 (11), p.1136-1142

2014

Volltextzugriff (PDF)

Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer

Journal of clinical oncology, 2020-09, Vol.38 (26), p.3042-3050

2020

Volltextzugriff (PDF)

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

The lancet oncology, 2013-08, Vol.14 (9), p.893-900

2013

Volltextzugriff (PDF)

Effects of a Group-Mediated Exercise and Dietary Intervention in the Treatment of Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Results From the IDEA-P Trial

Annals of behavioral medicine, 2018-04, Vol.52 (5), p.412-428

2018

Volltextzugriff (PDF)

Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 -2018)

Frontiers in oncology, 2023-06, Vol.13, p.1165188-1165188

2023

Volltextzugriff (PDF)

Assessment of Tumor Necrosis Factor Alpha Blockade As an Intervention to Improve Tolerability of Dose-Intensive Chemotherapy in Cancer Patients

Journal of clinical oncology, 2006-04, Vol.24 (12), p.1852-1859

2006

Volltextzugriff (PDF)

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial

International journal of cancer, 2015-04, Vol.136 (8), p.1856-1862

2015

Volltextzugriff (PDF)

Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer

Prostate cancer and prostatic diseases, 2019-12, Vol.22 (4), p.624-632

2019

Volltextzugriff (PDF)

Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)

Journal of clinical oncology, 2014-04, Vol.32 (11), p.1143-1150

2014

Volltextzugriff (PDF)

Efficacy of Peripheral Androgen Blockade in Prostate Cancer Patients With Biochemical Failure After Definitive Local Therapy: Results of Cancer and Leukemia Group B (CALGB) 9782

Cancer, 2012-09, Vol.118 (17), p.4139-4147

2012

Volltextzugriff (PDF)

Real-Time Scintigraphic Assessment of Intravenous Radium-223 Administration for Quality Control

BioMed research international, 2015-01, Vol.2015, p.324708-6

2015

Volltextzugriff (PDF)

Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma

Nature clinical practice. Nephrology, 2007-05, Vol.3 (5), p.287-293

2007

Volltextzugriff (PDF)

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)

Journal of patient-reported outcomes, 2018-06, Vol.2 (1), p.27-27, Article 27

2018

Volltextzugriff (PDF)

Electrochromic Materials and Devices

1, 2015

Volltextzugriff (PDF)

Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer

The oncologist (Dayton, Ohio), 2019-09, Vol.24 (9), p.1149-e807

2019

Volltextzugriff (PDF)

Multiparametric Flow Cytometric Analysis of Signal Transducer and Activator of Transcription 5 Phosphorylation in Immune Cell Subsets In vitro and following Interleukin-2 Immunotherapy

Clinical cancer research, 2006-10, Vol.12 (19), p.5850-5858

2006

Volltextzugriff (PDF)

The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells

The Journal of immunology (1950), 2015-09, Vol.195 (5), p.1995-2005

2015

Volltextzugriff (PDF)

Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center

Urologic oncology, 2008-03, Vol.26 (2), p.125-132

2008

Volltextzugriff (PDF)

High-Dose-Intensity MVAC for Advanced Renal Medullary Carcinoma: Report of Three Cases and Literature Review

Urology (Ridgewood, N.J.), 2008-09, Vol.72 (3), p.659-663

2008

Volltextzugriff (PDF)

Information Seeking and Satisfaction With Physician-Patient Communication Among Prostate Cancer Survivors

Health communication, 2008-01, Vol.23 (1), p.62-69

2008

Volltextzugriff (PDF)

The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer: Results From a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)

Cancer, 2013-10, Vol.119 (20), p.3636-3643

2013

Volltextzugriff (PDF)

Combination of Tomato and Soy Products for Men With Recurring Prostate Cancer and Rising Prostate Specific Antigen

Nutrition and cancer, 2008-03, Vol.60 (2), p.145-154

2008

Volltextzugriff (PDF)

Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancer

Oncotarget, 2017-09, Vol.8 (44), p.75822-75833

2017

Volltextzugriff (PDF)

A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors

Investigational new drugs, 2013-06, Vol.31 (3), p.685-695

2013

Volltextzugriff (PDF)

1 – 25 von 237

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(219)

Publikationsform

Sprache

Englisch
(237)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

Science & Technology
(153)
Life Sciences & Biomedicine
(122)
Humans
(94)
Male
(49)
Middle Aged
(46)
Aged
(41)
Female
(40)
Oncology
(40)
Biological And Medical Sciences
(35)
Adult
(31)
Medical Sciences
(27)
Engineering
(24)
Technology
(24)
Treatment Outcome
(24)
Surgery
(23)
Engineering, Electrical & Electronic
(21)
Materials Science
(20)
Materials Science, Multidisciplinary
(20)
Patients
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer

Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

Effects of a Group-Mediated Exercise and Dietary Intervention in the Treatment of Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: Results From the IDEA-P Trial

Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 -2018)

Assessment of Tumor Necrosis Factor Alpha Blockade As an Intervention to Improve Tolerability of Dose-Intensive Chemotherapy in Cancer Patients

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial

Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer

Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)

Efficacy of Peripheral Androgen Blockade in Prostate Cancer Patients With Biochemical Failure After Definitive Local Therapy: Results of Cancer and Leukemia Group B (CALGB) 9782

Real-Time Scintigraphic Assessment of Intravenous Radium-223 Administration for Quality Control

Proteinuria in a patient receiving anti-VEGF therapy for metastatic renal cell carcinoma

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)

Electrochromic Materials and Devices

Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer

Multiparametric Flow Cytometric Analysis of Signal Transducer and Activator of Transcription 5 Phosphorylation in Immune Cell Subsets In vitro and following Interleukin-2 Immunotherapy

The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells

Consumption of dietary supplements and over-the-counter and prescription medications in men participating in the Prostate Cancer Prevention Trial at an academic center

High-Dose-Intensity MVAC for Advanced Renal Medullary Carcinoma: Report of Three Cases and Literature Review

Information Seeking and Satisfaction With Physician-Patient Communication Among Prostate Cancer Survivors

The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy With Docetaxel in Patients With Metastatic Castrate-Resistant Prostate Cancer: Results From a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)

Combination of Tomato and Soy Products for Men With Recurring Prostate Cancer and Rising Prostate Specific Antigen

Analytic validation and real-time clinical application of an amplicon-based targeted gene panel for advanced cancer

A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors

Suchergebnisse filtern